Article

Researchers Outline Lessons Learned About Chronic Migraine Gleaned From Neuroimaging

Where do migraines begin in the brain and what has neuroimaging identified so far about how the disease alters pain processes and functioning? A recent article reviewed what is known so far.

A recent article in Frontiers in Neurology reviews neuroimaging studies of patients with chronic migraine and suggests that a better understanding of the pathophysiology will guide new treatments specifically designed for chronic migraine.

Migraine has a serious impact on quality of life, and the condition often leads to lost productivity and work days. But the mechanisms responsible for turning migraine into a chronic disease are not well understood. The researchers said that both episodic migraine and chronic migraine display "widespread functional and structural alterations of cortical and subcortical pain-related brain areas” and suggest that migraine could be viewed as a "spectrum disorder."

Chronic and episodic migraine have similar functional and structural alterations in brain regions implicated in the generation of the migraine attack and in pain processes, the authors explained. Patients with chronic migraine may have impaired attentive and executive function deficits as brain networks become impaired. Areas of the brain that are affected include the insula, prefrontal, anterior cingulate, and somatosensory cortex.

The analysis also said that patients with chronic migraine often experience more pronounced problems with the pain inhibitory network as well as increased sensitization of central pain pathways; these sections of the brain include the brainstem, cerebellum, basal ganglia, amygdala, frontal, temporal and occipital areas. Imaging of these areas show regions of increased and decreased gray matter volume. These changes, as they relate to increased pain, may be linked to more frequent attacks.

Where do migraines begin in the brain? So far, imaging studies suggest that a region of the brainstem called the dorsal pons, as well as the hypothalamus, play a role.

Imaging biomarkers may also be able to predict response to treatment, the study said. In addition, if predictive patterns can be determined from imaging, early prevention of migraine may be identified, the researchers wrote.

“Whether brain alterations are biomarkers that predispose migraine patients to chronification or reflect adaptive or maladaptive responses to the increasing headache frequency is still debated. Longitudinal studies including large sample size of patients with episodic and chronic migraine are warranted,” the authors said. “Future studies combining multimodal data, such as functional [magnetic resonance imaging] MRI, structural MRI and electroencephalographic data, might help us to achieve a better understanding of chronic migraine pathophysiology.”

Reference

Filippi M and Mesina R. The chronic migraine brain: What have we learned from neuroimaging? [published online January 9, 2020]. Frontiers in Neurology. https://doi.org/10.3389/fneur.2019.01356.

Related Videos
David Yeomans, PhD
David Yeomans, PhD
David Yeomans, PhD
David Yeomans, PhD
All of the panelists for this series
An image of all of the participants
An image of all of the participants
An image of all of the participants
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo